Live feed08:30:00·9dNEWSReleasevia QuantisnowAs the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR CongoByQuantisnow·Wall Street's wire, on your screen.NNVC· NanoViricides Inc.Health Care
